Collaboration combines Illumina's sequencing technologies and Illumina Connected Software with NVIDIA tools to develop biological foundation models SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology platforms for the analysis and interpretation of multiomic data, accelerating progress in clinical research, [...]

BRANFORD, Conn. -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, announces the launch of Platinum® Pro, its latest benchtop sequencer that sets a new standard in protein analysis. Designed to redefine efficiency and versatility in proteomics research, Platinum Pro is now available for ordering. Platinum Pro delivers a comprehensive solution for [...]

Professors Anders Bentien, Walter Gössler, and Gregory Offer are recognized for their work in battery research SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced Solutions Innovation Research Awards (SIRA) have been presented to Professor Anders Bentien of Aarhus University, Professor Walter Gössler of University of Graz, and Professor Gregory Offer of Imperial College London. These separate [...]

WALTHAM, Mass. & SAN DIEGO -- Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life science company democratizing access to advanced DNA and multi-omic sequencing solutions. This initiative builds upon Revvity's recent introduction of an automated next-generation sequencing (NGS) workflow [...]

WALTHAM, Mass. & SAN DIEGO -- Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life science company democratizing access to advanced DNA and multi-omic sequencing solutions. This initiative builds upon Revvity's recent introduction of an automated next-generation sequencing (NGS) workflow [...]

DALLAS -- Almaden Genomics has announced g.nome® 2.0, a significant upgrade to its flagship platform to empower researchers and biologists with enhanced data analysis capabilities and streamlined workflows. These enhancements further the company’s mission to make bioinformatics tools more accessible, efficient, and powerful for the life sciences industry. Key among the new features is the introduction [...]

Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tool for the job, launched Aunty today – the fastest and highest throughput protein stability characterization tool in all the realm. Aunty bestows upon researchers all the thermal, colloidal and long-term stability data that their hearts desire and [...]

Improved Metagenomics Classification, and Enhanced Long-Read Transcriptomics Pipelines We proudly present the OmicsBox Version 3.4 release that introduces a range of enhancements designed to address the evolving needs of modern genomics and transcriptomics research. A key highlight of OmicsBox 3.4 is the integration of CellKB, a robust cell-type prediction tool for single-cell RNA sequencing (scRNA-Seq) [...]

Strategic collaboration will introduce AI-enabled tools, optimized data sharing, bring your own cloud (BYOC) support, and enhanced scalability NEWTON, Mass. -- The Broad Institute of MIT and Harvard today announced a strategic collaboration with Manifold, a leader in research infrastructure for biomedical science, to develop a cutting-edge research platform. This initiative expands on Broad's vision for biomedical data analysis, secure sharing, and global [...]

REDWOOD CITY, Calif. -- Synthego, a leading supplier of CRISPR solutions, has entered a strategic licensing agreement with global biopharmaceutical company AstraZeneca. This agreement grants Synthego a global license to manufacture and distribute AstraZeneca's novel CRISPR gene editing enzyme, eSpOT-ON, recently published as engineered ePsCas9, to the worldwide research community. This state-of-the-art nuclease, developed by AstraZeneca, will [...]